Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Net Cash Flow (2016 - 2025)

Dare Bioscience's Net Cash Flow history spans 11 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 63.33% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $9.0 million, up 71.38%, while the annual FY2025 figure was $9.0 million, 71.38% up from the prior year.
  • Net Cash Flow reached $1.7 million in Q4 2025 per DARE's latest filing, down from $18.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $36.5 million in Q3 2021 to a low of -$14.8 million in Q1 2023.
  • Average Net Cash Flow over 5 years is $1.0 million, with a median of -$1.4 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: surged 87127.9% in 2021, then crashed 996.92% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $6.1 million in 2021, then tumbled by 196.9% to -$5.9 million in 2022, then soared by 41.06% to -$3.5 million in 2023, then surged by 230.34% to $4.5 million in 2024, then tumbled by 63.33% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Net Cash Flow are $1.7 million (Q4 2025), $18.0 million (Q3 2025), and -$5.3 million (Q2 2025).